Genomic susceptibility loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships

Archives of Neurology

Volumn 66, Issue 7, 2009, Pages 847-857

  Turner, Stephen T ^a   Fornage, Myriam ^b   Jack Jr , Clifford R ^a   Mosley, Thomas H ^c   Knopman, David S ^a   Kardia, Sharon L R ^d   Boerwinkle, Eric ^b   De Andrade, Mariza ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; AUTOSOME; BLOOD PRESSURE; BRAIN ATROPHY; BRAIN INJURY; BRAIN SIZE; BRAIN VENTRICLE; CAUCASIAN; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 22; DEMENTIA; ESSENTIAL HYPERTENSION; ETHNIC GROUP; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOMICS; GENOTYPE; HERITABILITY; HUMAN; HYPERTENSION; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE DIFFERENCE; SIBLING; STROKE; WHITE MATTER;

ATROPHY; BRAIN; CEREBRAL VENTRICLES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; DISEASE SUSCEPTIBILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOME, HUMAN; HUMANS; HYPERTENSION; LEUKOARAIOSIS; LINKAGE (GENETICS); MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SIBLINGS;

EID: 67650462946     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.110     Document Type: Article

References (79)

1. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707-710.
2. Campion D, Dumanchin C, Hannequin D, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65(3):664-670.
3. Jack CR Jr, O'Brien PC, Rettman DW, et al. FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging. 2001;14(6):668-676.
4. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28(3):652-659.
5. DeStefano AL, Atwood LD, Massaro JM, et al. Genome-wide scan for white matter hyperintensity: the Framingham Heart Study. Stroke. 2006;37(1):77-81.
6. Seshadri S, DeStefano AL, Au R, et al. Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. BMC Med Genet. 2007;8(suppl 1):S15.
7. Amos C, de Andrade M, Zhu D. Comparison of multivariate tests for genetic linkage. Hum Hered. 2001;51(3):133-144.
8. FBPP Investigators. Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension. 2002;39(1):3-9.
9. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
10. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63(1):259-266.
11. Lehmann EL, D'Abrera HJM. Nonparametrics: Statistical Methods Based on Ranks. San Francisco, CA: Holden-Day; 1975.
12. Peng B, Yu RK, Dehoff KL, Amos CI. Normalizing a large number of quantitative traits using empirical normal quantile transformation. BMC Proc. 2007;1(suppl 1):S156.
13. Lange K, Boehnke M. Extensions to pedigree analysis, IV: covariance components models for multivariate traits. Am J Med Genet. 1983;14(3):513-524.
14. Jaquish CE, Blangero J, Haffner SM, Stern MP, Maccluer JW. Quantitative genetics of dehydroepiandrosterone sulfate and its relation to possible cardiovascular disease risk factors in Mexican Americans. Hum Hered. 1996;46(6):301-309.
15. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. MERLIN: rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002;30(1):97-101.
16. de Andrade M, Atkinson EJ, Lunde EM, Amos CI, Chen J. Estimating Genetic Components of Variance in Family Studies Using the MULTIC Routines. Rochester, MN: Dept of Health Science Research, Mayo Clinic; 2006. Technical Report Series No. 78.
17. de Andrade M, Thiel TJ, Yu L, Amos CI. Assessing linkage on chromosome 5 using components of variance approach: univariate versus multivariate. Genet Epidemiol. 1997;14(6):773-778.
18. Bielinski SJ, Lynch AI, Miller MB, et al. Genome-wide linkage analysis for loci affecting pulse pressure: the Family Blood Pressure Program. Hypertension. 2005;46(6):1286-1293.
19. Domanski M, Norman J, Wolz M, Mitchell G, Pfeffer M. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension. 2001;38(4):793-797.
20. Sobel E, Sengul H, Weeks DE. Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees. Hum Hered. 2001;52(3):121-131.
21. Self S, Liang K-Y. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am Stat Assoc. 1987;82:605-610.
22. Morton NE. Significance levels in complex inheritance. Am J Hum Genet. 1998; 62(3):690-697.
23. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11(3):241-247.
24. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke. 1998;29(6):1177-1181.
25. Pfefferbaum A, Sullivan EV, Swan GE, Carmelli D. Brain structure in men remains highly heritable in the seventh and eighth decades of life. Neurobiol Aging. 2000;21(1):63-74.
26. Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke. 2004;35(7):1609-1613.
27. Carmelli D, Swan GE, Reed T, Wolf PA, Miller BL, DeCarli C. Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology. 1999;52(6):1119-1124.
28. Li YJ, Scott WK, Hedges DJ, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002;70(4):985-993.
29. Hicks AA, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol. 2002;52(5):549-555.
30. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000;26(3):268-270.
31. Niemann S, Muller U, Engelhardt D, Lohse P. Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. Hum Genet. 2003;113(1):92-94.
32. Cohn DH, Shohat T, Yahav M, et al. A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. Am J Hum Genet. 2000;67(3):647-651.
33. Takada D, Emi M, Ezura Y, et al. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred. J Hum Genet. 2002;47(12):656-664.
34. Pajukanta P, Lilja HE, Sinsheimer JS, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36(4):371-376.
35. Pajukanta P, Terwilliger JD, Perola M, et al. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet. 1999;64(5):1453-1463.
36. Wenzel K, Felix S, Kleber FX, et al. E-selectin polymorphism and atherosclerosis: an association study. Hum Mol Genet. 1994;3(11):1935-1937.
37. Takei T, Iida A, Nitta K, et al. Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet. 2002;70(3):781-786.
38. Chang YP, Liu X, Kim JD, et al. Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet. 2007;80(2):253-264.
39. Herrmann SM, Ricard S, Nicaud V, et al. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet. 1998;7(8):1277-1284.
40. Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64-77.
41. Kusari J, Verma US, Buse JB, Henry RR, Olefsky JM. Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest. 1991;88(4):1323-1330.
42. Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A. 2000;97(26):14478-14483.
43. Tatsuguchi M, Furutani M, Hinagata J, et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun. 2003;303(1):247-250.
44. Lambert JC, Luedecking-Zimmer E, Merrot S, et al. Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet. 2003;40(6):424-430.
45. Fogli A, Schiffmann R, Hugendubler L, et al. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet. 2004;12(7):561-566.
46. Gong M, Zhang H, Schulz H, et al. Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Hum Mol Genet. 2003;12(11):1273-1277.
47. Schuster H, Wienker TF, Toka HR, et al. Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. Hypertension. 1996;28(6):1085-1092.
48. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease: evidence for a new locus on chromosome 12. JAMA. 1997;278(15):1237-1241.
49. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44(4):601-607.
50. Dong C, Wang S, Li WD, Li D, Zhao H, Price RA. Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am J Hum Genet. 2003;72(1):115-124.
51. Souto JC, Blanco-Vaca F, Soria JM, et al. A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet. 2005;76(6):925-933.
52. Neumann HP, Bausch B, McWhinney SR, et al; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459-1466.
53. von Eckardstein A, Holz H, Sandkamp M, Weng W, Funke H, Assmann G. Apolipoprotein C-III(Lys58 - Glu): identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J Clin Invest. 1991;87(5):1724-1731.
54. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996;271(22):13055-13060.
55. Franceschini G, Sirtori CR, Capurso A II, Weisgraber KH, Mahley RW. A-IMilano apoprotein: decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest. 1980;66(5):892-900.
56. Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter JI, et al. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia: identification of different susceptibility haplotypes. J Clin Invest. 1997;99(5):953-961.
57. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294(5540):169-173.
58. Endo K, Yanagi H, Araki J, Hirano C, Yamakawa-Kobayashi K, Tomura S. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet. 2002;111(6):570-572.
59. Kort EN, Ballinger DG, Ding W, et al. Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23. Am J Hum Genet. 2000;66(6):1845-1856.
60. Vaughan CJ, Casey M, He J, et al. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation. 2001;103(20):2469-2475.
61. Prakash S, Chung KW, Sinha S, et al. Autosomal dominant progressive nephropathy with deafness: linkage to a new locus on chromosome 11q24. J Am Soc Nephrol. 2003;14(7):1794-1803.
62. Atwood LD, Heard-Costa NL, Cupples LA, Jaquish CE, Wilson PW, D'Agostino RB. Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. Am J Hum Genet. 2002;71(5):1044-1050.
63. Feitosa MF, Borecki IB, Rich SS, et al. Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet. 2002;70(1):72-82.
64. Hanson RL, Ehm MG, Pettitt DJ, et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet. 1998;63(4):1130-1138.
65. Chen YH, Lin SJ, Lin MW, et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet. 2002;111(1):1-8.
66. Tai ES, Demissie S, Cupples LA, et al. Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2002;22(5):805-810.
67. Ozaki K, Inoue K, Sato H, et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature. 2004;429(6987):72-75.
68. Elbaz A, Levecque C, Clavel J, et al. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol. 2004;55(3):430-434.
69. Manolio TA, Burke GL, O'Leary DH, et al; CHS Collaborative Research Group. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19(2):356-365.
70. Staessen JA, Richart T, Birkenhager WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension. 2007;49(3):389-400.
71. Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Biochem Pharmacol. 2004;67(8):1559-1567.
72. Berglund EO, Murai KK, Fredette B, et al. Ataxia and abnormal cerebellar micro-organization in mice with ablated contactin gene expression. Neuron. 1999;24(3):739-750.
73. Clark LN, Wang Y, Karlins E, et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006;67(10):1786- 1791.
74. Rajput A, Dickson DW, Robinson CA, et al. Parkinsonism, Lrrk2 G2019S, and tau neuropathology. Neurology. 2006;67(8):1506-1508.
75. Rogaeva E, Meng Y, Lee JH, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007;39(2):168-177.
76. Amos CI, Laing AE. A comparison of univariate and multivariate tests for genetic linkage. Genet Epidemiol. 1993;10(6):671-676.
77. Jacob HJ, Lindpaintner K, Lincoln SE, et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991;67(1):213-224.
78. Ikeda K, Yamori Y. Gene related to stroke in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1999;26(7):566-567.
79. Bourgain C, Genin E, Cox N, Clerget-Darpoux F. Are genome-wide association studies all that we need to dissect the genetic component of complex human diseases? Eur J Hum Genet. 2007;15(3):260-263.